Pesquisa | Biblioteca Virtual em Saúde

1.

Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.

Zingg, Daniel; Bhin, Jinhyuk; Yemelyanenko, Julia; Kas, Sjors M; Rolfs, Frank; Lutz, Catrin; Lee, Jessica K; Klarenbeek, Sjoerd; Silverman, Ian M; Annunziato, Stefano; Chan, Chang S; Piersma, Sander R; Eijkman, Timo; Badoux, Madelon; Gogola, Ewa; Siteur, Bjørn; Sprengers, Justin; de Klein, Bim; de Goeij-de Haas, Richard R; Riedlinger, Gregory M; Ke, Hua; Madison, Russell; Drenth, Anne Paulien; van der Burg, Eline; Schut, Eva; Henneman, Linda; van Miltenburg, Martine H; Proost, Natalie; Zhen, Huiling; Wientjens, Ellen; de Bruijn, Roebi; de Ruiter, Julian R; Boon, Ute; de Korte-Grimmerink, Renske; van Gerwen, Bastiaan; Féliz, Luis; Abou-Alfa, Ghassan K; Ross, Jeffrey S; van de Ven, Marieke; Rottenberg, Sven; Cuppen, Edwin; Chessex, Anne Vaslin; Ali, Siraj M; Burn, Timothy C; Jimenez, Connie R; Ganesan, Shridar; Wessels, Lodewyk F A; Jonkers, Jos.

Nature ; 608(7923): 609-617, 2022 08.

Artigo em Inglês | MEDLINE | ID: mdl-35948633

2.

Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.

Zingg, Daniel; Bhin, Jinhyuk; Yemelyanenko, Julia; Kas, Sjors M; Rolfs, Frank; Lutz, Catrin; Lee, Jessica K; Klarenbeek, Sjoerd; Silverman, Ian M; Annunziato, Stefano; Chan, Chang S; Piersma, Sander R; Eijkman, Timo; Badoux, Madelon; Gogola, Ewa; Siteur, Bjørn; Sprengers, Justin; de Klein, Bim; de Goeij-de Haas, Richard R; Riedlinger, Gregory M; Ke, Hua; Madison, Russell; Drenth, Anne Paulien; van der Burg, Eline; Schut, Eva; Henneman, Linda; van Miltenburg, Martine H; Proost, Natalie; Zhen, Huiling; Wientjens, Ellen; de Bruijn, Roebi; de Ruiter, Julian R; Boon, Ute; de Korte-Grimmerink, Renske; van Gerwen, Bastiaan; Féliz, Luis; Abou-Alfa, Ghassan K; Ross, Jeffrey S; van de Ven, Marieke; Rottenberg, Sven; Cuppen, Edwin; Chessex, Anne Vaslin; Ali, Siraj M; Burn, Timothy C; Jimenez, Connie R; Ganesan, Shridar; Wessels, Lodewyk F A; Jonkers, Jos.

Nature ; 609(7929): E13, 2022 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-36050473

3.

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study.

Abou-Alfa, Ghassan K; Sahai, Vaibhav; Hollebecque, Antoine; Vaccaro, Gina; Melisi, Davide; Al-Rajabi, Raed; Paulson, Andrew S; Borad, Mitesh J; Gallinson, David; Murphy, Adrian G; Oh, Do-Youn; Dotan, Efrat; Catenacci, Daniel V; Van Cutsem, Eric; Ji, Tao; Lihou, Christine F; Zhen, Huiling; Féliz, Luis; Vogel, Arndt.

Lancet Oncol ; 21(5): 671-684, 2020 05.

Artigo em Inglês | MEDLINE | ID: mdl-32203698

4.

FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements.

Bekaii-Saab, Tanios S; Valle, Juan W; Van Cutsem, Eric; Rimassa, Lorenza; Furuse, Junji; Ioka, Tatsuya; Melisi, Davide; Macarulla, Teresa; Bridgewater, John; Wasan, Harpreet; Borad, Mitesh J; Abou-Alfa, Ghassan K; Jiang, Ping; Lihou, Christine F; Zhen, Huiling; Asatiani, Ekaterine; Féliz, Luis; Vogel, Arndt.

Future Oncol ; 16(30): 2385-2399, 2020 10.

Artigo em Inglês | MEDLINE | ID: mdl-32677452

5.

Outcome of patients treated with palliative weekly paclitaxel plus cetuximab in recurrent head and neck cancer after failure of platinum-based therapy.

Sosa, Aaron E; Grau, Juan J; Feliz, Luis; Pereira, Verónica; Alcaraz, Diego; Muñoz-García, Carmen; Caballero, Miguel.

Eur Arch Otorhinolaryngol ; 271(2): 373-8, 2014 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-23644939

6.

Effect of FGFR2 Alterations on Overall and Progression-Free Survival in Patients Receiving Systemic Therapy for Intrahepatic Cholangiocarcinoma.

Abou-Alfa, Ghassan K; Bibeau, Kristen; Schultz, Nikolaus; Yaqubie, Amin; Millang, Brittanie; Ren, Haobo; Féliz, Luis.

Target Oncol ; 17(5): 517-527, 2022 09.

Artigo em Inglês | MEDLINE | ID: mdl-36114955

7.

Progression-Free Survival in Patients With Cholangiocarcinoma With or Without FGF/FGFR Alterations: A FIGHT-202 Post Hoc Analysis of Prior Systemic Therapy Response.

Bibeau, Kristen; Féliz, Luis; Lihou, Christine F; Ren, Haobo; Abou-Alfa, Ghassan K.

JCO Precis Oncol ; 6: e2100414, 2022 04.

Artigo em Inglês | MEDLINE | ID: mdl-35544727

8.

Validation and Characterization of FGFR2 Rearrangements in Cholangiocarcinoma with Comprehensive Genomic Profiling.

Silverman, Ian M; Li, Meijuan; Murugesan, Karthikeyan; Krook, Melanie A; Javle, Milind M; Kelley, Robin K; Borad, Mitesh J; Roychowdhury, Sameek; Meng, Wei; Yilmazel, Bahar; Milbury, Coren; Shewale, Shantanu; Feliz, Luis; Burn, Timothy C; Albacker, Lee A.

J Mol Diagn ; 24(4): 351-364, 2022 04.

Artigo em Inglês | MEDLINE | ID: mdl-35176488

9.

Clinicogenomic Analysis of FGFR2-Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib.

Silverman, Ian M; Hollebecque, Antoine; Friboulet, Luc; Owens, Sherry; Newton, Robert C; Zhen, Huiling; Féliz, Luis; Zecchetto, Camilla; Melisi, Davide; Burn, Timothy C.

Cancer Discov ; 11(2): 326-339, 2021 02.

Artigo em Inglês | MEDLINE | ID: mdl-33218975

10.

Comparative study on the use of three different near infrared spectroscopy recording methodologies for varietal discrimination of walnuts.

Nogales-Bueno, Julio; Feliz, Luis; Baca-Bocanegra, Berta; Hernández-Hierro, José Miguel; Heredia, Francisco José; Barroso, João Manuel; Rato, Ana Elisa.

Talanta ; 206: 120189, 2020 Jan 01.

Artigo em Inglês | MEDLINE | ID: mdl-31514826

11.

Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation.

García-Albéniz, Xabier; Gallego, Rosa; Hofheinz, Ralf Dieter; Fernández-Esparrach, Gloria; Ayuso-Colella, Juan Ramón; Bombí, Josep Antoni; Conill, Carles; Cuatrecasas, Miriam; Delgado, Salvadora; Ginés, Angels; Miquel, Rosa; Pagés, Mario; Pineda, Estela; Pereira, Verónica; Sosa, Aarón; Reig, Oscar; Victoria, Iván; Feliz, Luis; María de Lacy, Antonio; Castells, Antoni; Burkholder, Iris; Hochhaus, Andreas; Maurel, Joan.

World J Gastroenterol ; 20(42): 15820-9, 2014 Nov 14.

Artigo em Inglês | MEDLINE | ID: mdl-25400468

12.

Anti-vascular endothelial growth factor therapy in the era of personalized medicine.

Féliz, Luis R; Tsimberidou, Apostolia M.

Cancer Chemother Pharmacol ; 72(1): 1-12, 2013 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-23463481

13.

Situación epidemiológica de la drogadicción en República Dominicana / Epidemiological situation of the drug adiction in Domincan Republic

Feliz Feliz, Luis Elpidio.

Santo Domingo; s.n; 1994. [19] p.

Monografia em Espanhol | LILACS | ID: lil-158365

14.

Metodolología de investigación en salud

Féliz Féliz, Luis Elpidio.

Santo Domingo; Alfa & Omega; 1998. 285 p.

Monografia em Espanhol | LILACS | ID: lil-236787

15.

Survey on drug prevalence and attitudes in the Dominican Republic / Survey on drug prevalence and attitudes in the Dominican Republic

Jutkowitz, Joel M; Eu, Hongsook; Leavy, Matthew; Pagan, Lilian; Kunhart, Irma; Valleyron, Julio; Middlestadt, Susan; Feliz Feliz, Luis Elpidio; Hernandez, Orlando; Castillo, Maria; Conde, Aldo.

Arlington, VA; Development Associates, Inc; 1992. 78 p. tab.

Monografia em Inglês | PAHO | ID: pah-32545

Biblioteca Virtual em Saúde

Saúde Pública Brasil

Sua seleção (0)

Formato de exportação:

Exportar: